Issue 59, 2018

Tumor-selective catalytic nanosystem for activatable theranostics

Abstract

A novel tumor-selective catalytic nanosystem that enables efficient chemodynamic therapy (CDT) and activatable fluorescence imaging in H2O2-rich tumor microenvironments has been developed.

Graphical abstract: Tumor-selective catalytic nanosystem for activatable theranostics

Supplementary files

Article information

Article type
Communication
Submitted
16 May 2018
Accepted
29 Jun 2018
First published
29 Jun 2018

Chem. Commun., 2018,54, 8214-8217

Tumor-selective catalytic nanosystem for activatable theranostics

L. Duan, Y. Wang, J. Liu, Y. Wang, N. Li and J. Jiang, Chem. Commun., 2018, 54, 8214 DOI: 10.1039/C8CC03922D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements